In our meta-analysis, we found tumor PD-L1 expression to be a robust prognostic factor for the general effect of PD-1 blockade in lymphoma, which is consistent with the findings of a previous network meta-analysis on advanced NSCLC [21]. Here, CD274 is linked to lymphoma.